SIRT1 Gene
protein-coding GIFtS: 66
GCID: GC10P069644
|
|
sirtuin 1(Previous names: sirtuin (silent mating type information regulation 2, S....)
| |
Aliases for SIRT1 gene
(According to
1HGNC,
2Entrez Gene,
3UniProtKB/Swiss-Prot,
4UniProtKB/TrEMBL, 5OMIM, 6GeneLoc,
7Ensembl,
8DME,
9miRBase,
and/or 10fRNAdb) About This Section
|
| Aliases |
|---|
| Sirtuin 11 2 | | Sirtuin (Silent Mating Type Information Regulation 2, S. Cerevisiae, Homolog) 11 | | SIR2L11 2 3 5 | | SIR2alpha2 | | Regulatory Protein SIR2 Homolog 12 3 | | NAD-Dependent Deacetylase Sirtuin-12 | | HSIR21 | | NAD-Dependent Protein Deacetylase Sirtuin-12 | | HSIRT11 | | Sir2-Like 12 | | SIR2-Like Protein 12 3 | | Sirtuin Type 12 | | Sirtuin (Silent Mating Type Information Regulation 2 Homolog) 1 (S. Cerevisiae)1 | | EC 3.5.1.-3 |
Export aliases for SIRT1 gene to outside databasesPrevious GC identifers: GC10P068455 GC10P068731 GC10P069536 GC10P068989 GC10P069314 GC10P063643 |
Summaries for SIRT1 gene(According to Entrez Gene,
Tocris Bioscience,
Wikipedia's
Gene Wiki,
PharmGKB,
UniProtKB/Swiss-Prot,
and/or
UniProtKB/TrEMBL)
About This Section
| Entrez Gene summary for SIRT1: This gene encodes a member of the sirtuin family of proteins, homologs to the yeast Sir2 protein. Members of thesirtuin family are characterized by a sirtuin core domain and grouped into four classes. The functions of humansirtuins have not yet been determined; however, yeast sirtuin proteins are known to regulate epigenetic gene silencingand suppress recombination of rDNA. Studies suggest that the human sirtuins may function as intracellular regulatoryproteins with mono-ADP-ribosyltransferase activity. The protein encoded by this gene is included in class I of thesirtuin family. Alternative splicing results in multiple transcript variants. (provided by RefSeq, Dec 2008) UniProtKB/Swiss-Prot: SIR1_HUMAN, Q96EB6Function: NAD-dependent protein deacetylase that links transcriptional regulation directly to intracellular energeticsand participates in the coordination of several separated cellular functions such as cell cycle, response to DNAdamage, metobolism, apoptosis and autophagy. Can modulate chromatin function through deacetylation of histones and canpromote alterations in the methylation of histones and DNA, leading to transcriptional repression. Deacetylates abroad range of transcription factors and coregulators, thereby regulating target gene expression positively andnegatively. Serves as a sensor of the cytosolic ratio of NAD(+)/NADH which is altered by glucose deprivation andmetabolic changes associated with caloric restriction. Is essential in skeletal muscle cell differentiation and inresponse to low nutrients mediates the inhibitory effect on skeletal myoblast differentiation which also involves5'-AMP-activated protein kinase (AMPK) and nicotinamide phosphoribosyltransferase (NAMPT). Component of the eNoSC(energy-dependent nucleolar silencing) complex, a complex that mediates silencing of rDNA in response to intracellularenergy status and acts by recruiting histone-modifying enzymes. The eNoSC complex is able to sense the energy statusof cell: upon glucose starvation, elevation of NAD(+)/NADP(+) ratio activates SIRT1, leading to histone H3deacetylation followed by dimethylation of H3 at 'Lys-9' (H3K9me2) by SUV39H1 and the formation of silent chromatin inthe rDNA locus. Deacetylates 'Lys-266' of SUV39H1, leading to its activation. Inhibits skeletal muscle differentiationby deacetylating PCAF and MYOD1. Deacetylates H2A and 'Lys-26' of HIST1H1E. Deacetylates 'Lys-16' of histone H4 (invitro). Involved in NR0B2/SHP corepression function through chromatin remodeling: Recruited to LRH1 target genepromoters by NR0B2/SHP thereby stimulating histone H3 and H4 deacetylation leading to transcriptional repression.Proposed to contribute to genomic integrity via positive regulation of telomere length; however, reports onlocalization to pericentromeric heterochromatin are conflicting. Proposed to play a role in constitutiveheterochromatin (CH) formation and/or maintenance through regulation of the available pool of nuclear SUV39H1. Uponoxidative/metabolic stress decreases SUV39H1 degradation by inhibiting SUV39H1 polyubiquitination by MDM2. Thisincrease in SUV39H1 levels enhances SUV39H1 turnover in CH, which in turn seems to accelerate renewal of theheterochromatin which correlates with greater genomic integrity during stress response. Deacetylates 'Lys-382' ofp53/TP53 and impairs its ability to induce transcription-dependent proapoptotic program and modulate cell senescence.Deacetylates TAF1B and thereby represses rDNA transcription by the RNA polymerase I. Deacetylates MYC, promotes theassociation of MYC with MAX and decreases MYC stability leading to compromised transformational capability.Deacetylates FOXO3 in response to oxidative stress thereby increasing its ability to induce cell cycle arrest andresistance to oxidative stress but inhibiting FOXO3-mediated induction of apoptosis transcriptional activity; alsoleading to FOXO3 ubiquitination and protesomal degradation. Appears to have a similar effect on MLLT7/FOXO4 inregulation of transcriptional activity and apoptosis. Deacetylates DNMT1; thereby impairs DNMT1methyltransferase-independent transcription repressor activity, modulates DNMT1 cell cycle regulatory function andDNMT1-mediated gene silencing. Deacetylates RELA/NF-kappa-B p65 thereby inhibiting its transactivating potential andaugments apoptosis in response to TNF-alpha. Deacetylates HIF1A, KAT5/TIP60, RB1 and HIC1. Deacetylates FOXO1resulting in its nuclear retention and enhancement of its transcriptional activity leading to increasedgluconeogenesis in liver. Inhibits E2F1 transcriptional activity and apoptotic function, possibly by deacetylation.Involved in HES1- and HEY2-mediated transcriptional repression. In cooperation with MYCN seems to be involved intranscriptional repression of DUSP6/MAPK3 leading to MYCN stabilization by phosphorylation at 'Ser-62'. DeacetylatesMEF2D. Required for antagonist-mediated transcription suppression of AR-dependent genes which may be linked to localdeacetylation of histone H3. Represses HNF1A-mediated transcription. Required for the repression of ESRRG by CREBZF.Modulates AP-1 transcription factor activity. Deacetylates NR1H3 AND NR1H2 and deacetylation of NR1H3 at 'Lys-434'positively regulates transcription of NR1H3:RXR target genes, promotes NR1H3 proteosomal degradation and results incholesterol efflux; a promoter clearing mechanism after reach round of transcription is proposed. Involved in lipidmetabolism. Implicated in regulation of adipogenesis and fat mobilization in white adipocytes by repression of PPARGwhich probably involves association with NCOR1 and SMRT/NCOR2. Deacetylates ACSS2 leading to its activation, andHMGCS1. Involved in liver and muscle metabolism. Through deacteylation and activation of PPARGC1A is required toactivate fatty acid oxidation in skeletel muscle under low-glucose conditions and is involved in glucose homeostasis.Involved in regulation of PPARA and fatty acid beta-oxidation in liver. Involved in positive regulation of insulinsecretion in pancreatic beta cells in response to glucose; the function seems to imply transcriptional repression ofUCP2. Proposed to deacetylate IRS2 thereby facilitating its insuline-induced tyrosine phosphorylation. DeacetylatesSREBF1 isoform SREBP-1C thereby decreasing its stability and transactivation in lipogenic gene expression. Involved inDNA damage response by repressing genes which are involved in DNA repair, such as XPC and TP73, deacetylatingXRCC6/Ku70, and faciliting recruitment of additional factors to sites of damaged DNA, such as SIRT1-deacetylated NBNcan recruit ATM to initiate DNA repair and SIRT1-deacetylated XPA interacts with RPA2. Also involved in DNA repair ofDNA double-strand breaks by homologous recombination and specifically single-strand annealing independently ofXRCC6/Ku70 and NBN. Transcriptional suppression of XPC probably involves an E2F4:RBL2 suppressor complex and proteinkinase B (AKT) signaling. Transcriptional suppression of TP73 probably involves E2F4 and PCAF. Deacetylates WRNthereby regulating its helicase and exonuclease activities and regulates WRN nuclear translocation in response to DNAdamage. Deacetylates APEX1 at 'Lys-6' and 'Lys-7' and stimulates cellular AP endonuclease activity by promoting theassociation of APEX1 to XRCC1. Increases p53/TP53-mediated transcription-independent apoptosis by blocking nucleartranslocation of cytoplasmic p53/TP53 and probably redirecting it to mitochondria. Deacetylates XRCC6/Ku70 at'Lys-539' and 'Lys-542' causing it to sequester BAX away from mitochondria thereby inhibiting stress-inducedapoptosis. Is involved in autophagy, presumably by deacetylating ATG5, ATG7 and MAP1LC3B/ATG8. Deacetylates AKT1 whichleads to enhanced binding of AKT1 and PDK1 to PIP3 and promotes their activation. Proposed to play role in regulationof STK11/LBK1-dependent AMPK signaling pathways implicated in cellular senescence which seems to involve theregulation of the acetylation status of STK11/LBK1. Can deacetylate STK11/LBK1 and thereby increase its activity,cytoplasmic localization and association with STRAD; however, the relevance of such activity in normal cells isunclear. In endothelial cells is shown to inhibit STK11/LBK1 activity and to promote its degradation. DeacetylatesSMAD7 at 'Lys-64' and 'Lys-70' thereby promoting its degradation. Deacetylates CIITA and augments its MHC class IItransacivation and contributes to its stability. Deacteylates MECOM/EVI1. Isoform 2 is shown to deacetylate 'Lys-382'of p53/TP53, however with lower activity than isoform 1. In combination, the two isoforms exert an additive effect.Isoform 2 regulates p53/TP53 expression and cellular stress response and is in turn repressed by p53/TP53 presenting aSIRT1 isoform-dependent auto-regulatory loop. In case of HIV-1 infection, interacts with and deacetylates the viralTat protein. The viral Tat protein inhibits SIRT1 deacetylation activity toward RELA/NF-kappa-B p65, therebypotentiates its transcriptional activity and SIRT1 is proposed to contribute to T-cell hyperactivation duringinfectionFunction: SirtT1 75 kDa fragment: catalytically inactive 75SirT1 may be involved in regulation of apoptosis. May beinvolved in protecting chondrocytes from apoptotic death by associating with cytochrome C and interfering withapoptosome assembly
summary
for SIRT1: Silent information regulator (Sir2)-like family deacetylases (also known as sirtuins) are a group of enzymes closely related to histone deacetylases. These enzymes can be found in the cytoplasm, mitochondria or nucleus and are ubiquitously expressed. Sir2-like family deacetylases catalyze the removal of acetyl groups from lysine residues in histones and non-histone proteins, which is coupled to NAD+ hydrolysis. In general, sirtuins do not act autonomously but as components of large multiprotein complexes, such as pRb-E2F and mSin3A, that mediate important transcription regulatory pathways. Sirtuins have a role in regulation of transcription and apoptosis leading to substantial interest in inhibitors of these enzymes as possible antineoplastic agents. In addition, Sir2-like family deacteylases are involved in the normal ageing process through their role in resistance to cellular stress. Gene Wiki entry for SIRT1 (Sirtuin 1)
|
Genomic Views for SIRT1 gene
(According to
GeneLoc and/or
HGNC, and/or
Entrez Gene (NCBI build 37),
and/or miRBase,
Genomic Views according to
UCSC (hg19) and
Ensembl (release 69),
Regulatory elements and Epigenetics data according to
QIAGEN,
SABiosciences, and/or
SwitchGear Genomics) About This Section
| RefSeq DNA sequence:- NC_000010.10 NC_018921.1 NT_030059.13
Regulatory elements: SABiosciences Regulatory transcription factor binding sites in the SIRT1 gene promoter: N-Myc MyoD C/EBPalpha Other transcription factors
Search SABiosciences Chromatin IP Primers for SIRT1
Epigenetics:
|  | QIAGEN PyroMark CpG Assay predesigned Pyrosequencing DNA Methylation assays in human, mouse, rat SIRT1 |
Genomic Location: Genomic View: UCSC Golden Path with GeneCards custom track
Entrez Gene cytogenetic band: 10q21.3 Ensembl cytogenetic band: 10q21.3 HGNC cytogenetic band: 10q21SIRT1 Gene in genomic location: bands according to Ensembl, locations according to
(and/or Entrez Gene and/or Ensembl if different)

GeneLoc information about chromosome 10 GeneLoc Exon Structure GeneLoc location for GC10P069644: view genomic region
(about GC identifiers)
Start:
|
69,644,427 bp from pter |
End:
|
69,678,147 bp from pter |
Size:
|
33,721 bases |
Orientation:
|
plus strand |
|
Proteins for SIRT1 gene
(According to
1UniProtKB,
HORDE,
neXtProt,
Ensembl,
and/or Reactome,
Modification sites according to 2PhosphoSitePlus,
Specific Peptides from DME,
Protein expression images according to data from SPIRE MOPED and PaxDb,
RefSeq according to NCBI,
PDB rendering according to OCA and/or Proteopedia,
Recombinant Proteins
from
EMD Millipore,
R&D Systems,
GenScript,
Enzo Life Sciences,
OriGene,
Novus Biologicals,
Sino Biological,
ProSpec, and/or
Uscn,
Biochemical Assays by
EMD Millipore,
R&D Systems,
OriGene,
GenScript,
Cell Signaling Technology,
Enzo Life Sciences, and/or
Uscn,
Ontologies according to Gene
Ontology Consortium 01 Mar 2013 and
Entrez Gene,
Antibodies by
EMD Millipore,
R&D Systems,
GenScript,
Cell Signaling Technology,
OriGene,
Novus Biologicals,
Thermo Fisher Scientific,
Abcam, and/or
Uscn)
About This Section
| UniProtKB/Swiss-Prot: SIR1_HUMAN, Q96EB6 (See
protein sequence)Recommended Name: NAD-dependent protein deacetylase sirtuin-1 Size: 747 amino acids; 81681 Da
Cofactor: Binds 1 zinc ion per subunit (By similarity)
Subunit: Found in a complex with PCAF and MYOD1. Interacts with FOXO1; the interaction deacetylates FOXO1, resulting inits nuclear retention and promotion of its transcriptional activity Component of the eNoSC complex, composed of SIRT1,SUV39H1 and RRP8. Interacts with HES1, HEY2 and PML. Interacts with RPS19BP1/AROS. Interacts with KIAA1967/DBC1 (viaN-terminus); the interaction disrupts the interaction between SIRT1 and p53/TP53. Interacts with SETD7; theinteraction induces the dissociation of SIRT1 from p53/TP53 and increases p53/TP53 activity. Interacts with MYCN,NR1I2, CREBZF, TSC2, TLE1, FOS, JUN, NR0B2, PPARG, NCOR, IRS1, IRS2 and NMNAT1. Interacts with HNF1A; the interactionoccurs under nutrient restriction. Interacts with SUZ12; the interaction mediates the association with the PRC4histone methylation complex which is specific as an association with PCR2 and PCR3 complex variants is not found.Interacts with HIV-1 tat
Subcellular location: Nucleus, PML body. Cytoplasm. Note=Recruited to the nuclear bodies via its interaction with PML.Colocalized with APEX1 in the nucleus. May be found in nucleolus, nuclear euchromatin, heterochromatin and innermembrane. Shuttles between nucleus and cytoplasm
Subcellular location: SirtT1 75 kDa fragment: Cytoplasm. Mitochondrion
Miscellaneous: Red wine, which contains resveratrol, may participate in activation of sirtuin proteins, and maytherefore participate in an extended lifespan as it has been observed in yeast
Miscellaneous: Calf histone H1 is used as substrate in the in vitro deacetylation assay (PubMed:15469825). As, in vivo,interaction occurs between SIRT1 with HIST1H1E, deacetylation has been validated only for HIST1H1E
Miscellaneous: The reported ADP-ribosyltransferase activity of sirtuins is likely some inefficient side reaction of thedeacetylase activity and may not be physiologically relevant (PubMed:19220062)
Sequence caution: Sequence=AAH12499.1; Type=Erroneous initiation; Note=Translation N-terminally extended;
1 PDB 3D structure from and Proteopedia for SIRT1:4I5I (3D)
 
Secondary accessions: Q2XNF6 Q5JVQ0 Q9GZR9 Q9Y6F0Alternative splicing: 2 isoforms: Q96EB6-1 Q96EB6-2 Explore the universe of human proteins at neXtProt for SIRT1: NX_Q96EB6
Post-translational modifications:
Methylated on multiple lysine residues; methylation is enhanced after DNA damage and is dispensable for deacetylaseactivity toward p53/TP531
Phosphorylated. Phosphorylated by STK4/MST1, resulting in inhibition of SIRT1-mediated p53/TP53 deacetylation.Phosphorylation by MAPK8/JNK1 at Ser-27, Ser-47, and Thr-530 leads to increased nuclear localization and enzymaticactivity. Phosphorylation at Thr-530 by DYRK1A and DYRK3 acivates deacetylase activity and promotes cell survival.Phosphorylation by mammalian target of rapamycin complex 1 (mTORC1) at Ser-47 inhibits deacetylation activity.Phosphorylated by CaMK2, leading to increased p53/TP53 and NF-kappa-B p65/RELA deacetylation activity (By similarity).Phosphorylation at Ser-27 implicating MAPK9 is linked to protein stability. There is some ambiguity for somephosphosites: Ser-159/Ser-162 and Thr-544/Ser-5451
Proteolytically cleaved by cathepsin B upon TNF-alpha treatment to yield catalytic inactive but stable SirtT1 75 kDafragment (75SirT1)1
S-nitrosylated by GAPDH, leading to inhibit the NAD-dependent protein deacetylase activity (By similarity)1
View modification sites using PhosphoSitePlus2View neXtProt modification sites for NX_Q96EB6 SIRT1 Protein expression data from MOPED and PaxDb: About this image 
REFSEQ proteins (2 alternative transcripts):
NP_001135970.1 NP_036370.2 ENSEMBL proteins: ENSP00000212015 ENSP00000384508 ENSP00000384063 ENSP00000409208 Human Recombinant Protein Products:
Gene Ontology (GO): 5/13 cellular component terms (GO ID links to tree view) (see all 13): About this table
SIRT1 for ontologies About GeneDecksing
SIRT1 Antibody Products: Assay Products for SIRT1: |
Protein
Domains / Families for SIRT1 gene(According to InterPro, ProtoNet,
UniProtKB, and/or BLOCKS,
Sets of similar genes according to GeneDecks)
About This Section
|
SIRT1 for domains About GeneDecksing
3 InterPro domains/families:Graphical View of Domain Structure for InterPro Entry Q96EB6ProtoNet protein and cluster: Q96EB6 1 Blocks protein family: IPB003000 Silent information regulator protein Sir2
UniProtKB/Swiss-Prot: SIR1_HUMAN, Q96EB6Similarity: Belongs to the sirtuin family. Class I subfamilySimilarity: Contains 1 deacetylase sirtuin-type domain |
Function for SIRT1 gene
(According to 1UniProtKB,
Genatlas,
LifeMap Discovery™,
IUBMB, and/or
2DME,
Human phenotypes from GenomeRNAi,
Animal models from MGI Mar 06 2013,
bound targets from SABiosciences,
miRNA Gene Targets from miRTarBase
shRNA from
OriGene,
RNAi from
EMD Millipore,
siRNAs from
OriGene,
QIAGEN,
microRNA from QIAGEN,
Gene Editing from DNA2.0,
Clones from EMD Millipore,
OriGene,
SwitchGear Genomics,
GenScript,
Sino Biological,
DNA2.0,
and Vector BioLabs,
Cell Lines from GenScript,
LifeMap BioReagents,
In Situ Hybridization Assays from Advanced Cell Diagnostics,
Ontologies according to Gene Ontology Consortium 01 Mar 2013 via
Entrez Gene.)
About This Section
| Function Summary: UniProtKB/Swiss-Prot: SIR1_HUMAN, Q96EB6Function: NAD-dependent protein deacetylase that links transcriptional regulation directly to intracellular energeticsand participates in the coordination of several separated cellular functions such as cell cycle, response to DNAdamage, metobolism, apoptosis and autophagy. Can modulate chromatin function through deacetylation of histones and canpromote alterations in the methylation of histones and DNA, leading to transcriptional repression. Deacetylates abroad range of transcription factors and coregulators, thereby regulating target gene expression positively andnegatively. Serves as a sensor of the cytosolic ratio of NAD(+)/NADH which is altered by glucose deprivation andmetabolic changes associated with caloric restriction. Is essential in skeletal muscle cell differentiation and inresponse to low nutrients mediates the inhibitory effect on skeletal myoblast differentiation which also involves5'-AMP-activated protein kinase (AMPK) and nicotinamide phosphoribosyltransferase (NAMPT). Component of the eNoSC(energy-dependent nucleolar silencing) complex, a complex that mediates silencing of rDNA in response to intracellularenergy status and acts by recruiting histone-modifying enzymes. The eNoSC complex is able to sense the energy statusof cell: upon glucose starvation, elevation of NAD(+)/NADP(+) ratio activates SIRT1, leading to histone H3deacetylation followed by dimethylation of H3 at 'Lys-9' (H3K9me2) by SUV39H1 and the formation of silent chromatin inthe rDNA locus. Deacetylates 'Lys-266' of SUV39H1, leading to its activation. Inhibits skeletal muscle differentiationby deacetylating PCAF and MYOD1. Deacetylates H2A and 'Lys-26' of HIST1H1E. Deacetylates 'Lys-16' of histone H4 (invitro). Involved in NR0B2/SHP corepression function through chromatin remodeling: Recruited to LRH1 target genepromoters by NR0B2/SHP thereby stimulating histone H3 and H4 deacetylation leading to transcriptional repression.Proposed to contribute to genomic integrity via positive regulation of telomere length; however, reports onlocalization to pericentromeric heterochromatin are conflicting. Proposed to play a role in constitutiveheterochromatin (CH) formation and/or maintenance through regulation of the available pool of nuclear SUV39H1. Uponoxidative/metabolic stress decreases SUV39H1 degradation by inhibiting SUV39H1 polyubiquitination by MDM2. Thisincrease in SUV39H1 levels enhances SUV39H1 turnover in CH, which in turn seems to accelerate renewal of theheterochromatin which correlates with greater genomic integrity during stress response. Deacetylates 'Lys-382' ofp53/TP53 and impairs its ability to induce transcription-dependent proapoptotic program and modulate cell senescence.Deacetylates TAF1B and thereby represses rDNA transcription by the RNA polymerase I. Deacetylates MYC, promotes theassociation of MYC with MAX and decreases MYC stability leading to compromised transformational capability.Deacetylates FOXO3 in response to oxidative stress thereby increasing its ability to induce cell cycle arrest andresistance to oxidative stress but inhibiting FOXO3-mediated induction of apoptosis transcriptional activity; alsoleading to FOXO3 ubiquitination and protesomal degradation. Appears to have a similar effect on MLLT7/FOXO4 inregulation of transcriptional activity and apoptosis. Deacetylates DNMT1; thereby impairs DNMT1methyltransferase-independent transcription repressor activity, modulates DNMT1 cell cycle regulatory function andDNMT1-mediated gene silencing. Deacetylates RELA/NF-kappa-B p65 thereby inhibiting its transactivating potential andaugments apoptosis in response to TNF-alpha. Deacetylates HIF1A, KAT5/TIP60, RB1 and HIC1. Deacetylates FOXO1resulting in its nuclear retention and enhancement of its transcriptional activity leading to increasedgluconeogenesis in liver. Inhibits E2F1 transcriptional activity and apoptotic function, possibly by deacetylation.Involved in HES1- and HEY2-mediated transcriptional repression. In cooperation with MYCN seems to be involved intranscriptional repression of DUSP6/MAPK3 leading to MYCN stabilization by phosphorylation at 'Ser-62'. DeacetylatesMEF2D. Required for antagonist-mediated transcription suppression of AR-dependent genes which may be linked to localdeacetylation of histone H3. Represses HNF1A-mediated transcription. Required for the repression of ESRRG by CREBZF.Modulates AP-1 transcription factor activity. Deacetylates NR1H3 AND NR1H2 and deacetylation of NR1H3 at 'Lys-434'positively regulates transcription of NR1H3:RXR target genes, promotes NR1H3 proteosomal degradation and results incholesterol efflux; a promoter clearing mechanism after reach round of transcription is proposed. Involved in lipidmetabolism. Implicated in regulation of adipogenesis and fat mobilization in white adipocytes by repression of PPARGwhich probably involves association with NCOR1 and SMRT/NCOR2. Deacetylates ACSS2 leading to its activation, andHMGCS1. Involved in liver and muscle metabolism. Through deacteylation and activation of PPARGC1A is required toactivate fatty acid oxidation in skeletel muscle under low-glucose conditions and is involved in glucose homeostasis.Involved in regulation of PPARA and fatty acid beta-oxidation in liver. Involved in positive regulation of insulinsecretion in pancreatic beta cells in response to glucose; the function seems to imply transcriptional repression ofUCP2. Proposed to deacetylate IRS2 thereby facilitating its insuline-induced tyrosine phosphorylation. DeacetylatesSREBF1 isoform SREBP-1C thereby decreasing its stability and transactivation in lipogenic gene expression. Involved inDNA damage response by repressing genes which are involved in DNA repair, such as XPC and TP73, deacetylatingXRCC6/Ku70, and faciliting recruitment of additional factors to sites of damaged DNA, such as SIRT1-deacetylated NBNcan recruit ATM to initiate DNA repair and SIRT1-deacetylated XPA interacts with RPA2. Also involved in DNA repair ofDNA double-strand breaks by homologous recombination and specifically single-strand annealing independently ofXRCC6/Ku70 and NBN. Transcriptional suppression of XPC probably involves an E2F4:RBL2 suppressor complex and proteinkinase B (AKT) signaling. Transcriptional suppression of TP73 probably involves E2F4 and PCAF. Deacetylates WRNthereby regulating its helicase and exonuclease activities and regulates WRN nuclear translocation in response to DNAdamage. Deacetylates APEX1 at 'Lys-6' and 'Lys-7' and stimulates cellular AP endonuclease activity by promoting theassociation of APEX1 to XRCC1. Increases p53/TP53-mediated transcription-independent apoptosis by blocking nucleartranslocation of cytoplasmic p53/TP53 and probably redirecting it to mitochondria. Deacetylates XRCC6/Ku70 at'Lys-539' and 'Lys-542' causing it to sequester BAX away from mitochondria thereby inhibiting stress-inducedapoptosis. Is involved in autophagy, presumably by deacetylating ATG5, ATG7 and MAP1LC3B/ATG8. Deacetylates AKT1 whichleads to enhanced binding of AKT1 and PDK1 to PIP3 and promotes their activation. Proposed to play role in regulationof STK11/LBK1-dependent AMPK signaling pathways implicated in cellular senescence which seems to involve theregulation of the acetylation status of STK11/LBK1. Can deacetylate STK11/LBK1 and thereby increase its activity,cytoplasmic localization and association with STRAD; however, the relevance of such activity in normal cells isunclear. In endothelial cells is shown to inhibit STK11/LBK1 activity and to promote its degradation. DeacetylatesSMAD7 at 'Lys-64' and 'Lys-70' thereby promoting its degradation. Deacetylates CIITA and augments its MHC class IItransacivation and contributes to its stability. Deacteylates MECOM/EVI1. Isoform 2 is shown to deacetylate 'Lys-382'of p53/TP53, however with lower activity than isoform 1. In combination, the two isoforms exert an additive effect.Isoform 2 regulates p53/TP53 expression and cellular stress response and is in turn repressed by p53/TP53 presenting aSIRT1 isoform-dependent auto-regulatory loop. In case of HIV-1 infection, interacts with and deacetylates the viralTat protein. The viral Tat protein inhibits SIRT1 deacetylation activity toward RELA/NF-kappa-B p65, therebypotentiates its transcriptional activity and SIRT1 is proposed to contribute to T-cell hyperactivation duringinfectionFunction: SirtT1 75 kDa fragment: catalytically inactive 75SirT1 may be involved in regulation of apoptosis. May beinvolved in protecting chondrocytes from apoptotic death by associating with cytochrome C and interfering withapoptosome assemblyCatalytic activity: NAD(+) + an acetylprotein = nicotinamide + O-acetyl-ADP-ribose + a proteinEnzyme regulation: Inhibited by nicotinamide. Activated by resveratrol (3,5,4'-trihydroxy-trans-stilbene), butein(3,4,2',4'-tetrahydroxychalcone), piceatannol (3,5,3',4'-tetrahydroxy-trans-stilbene), Isoliquiritigenin(4,2',4'-trihydroxychalcone), fisetin (3,7,3',4'-tetrahydroxyflavone) and quercetin (3,5,7,3',4'-pentahydroxyflavone).MAPK8/JNK1 and RPS19BP1/AROS act as positive regulators of deacetylation activity. Negatively regulated byKIAA1967/DBC1Induction: Up-regulated by methyl methanesulfonate (MMS). In H293T cells by presence of rat calorie restriction (CR)serumEnzyme Number (IUBMB): EC 3.5.1.-1
Clone Products: |  | Browse Clones for the Expression of Recombinant Proteins Available from EMD Millipore | |  | OriGene Myc/DDK tagged cDNA clones in CMV expression vector in human, mouse, rat for SIRT1 (see all 5) OriGene untagged cDNA clones in CMV expression vector in human, mouse, rat for SIRT1 (see all 2) OriGene custom cloning services – gene synthesis, subcloning, mutagenesis,
variant library, vector shuttling 
| |  | GenScript: all cDNA clones in your preferred vector (see all 2): SIRT1 (NM_012238) | |  | Browse Sino Biological Human cDNA Clones | |  | DNA2.0 Custom Codon Optimized Gene
Synthesis Service for SIRT1 | |  | Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat SIRT1  |
In Situ Assay Products: |
| Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for SIRT1 |
Gene Ontology (GO): 5/19 molecular function terms (GO ID links to tree view) (see all 19): About this table
SIRT1 for ontologies About GeneDecksing
3 GenomeRNAi human phenotypes for SIRT1: Animal Models: Mouse knock-outs for SIRT1: Sirt1tm1.1Cxd Sirt1tm1Fwa Sirt1tm1Mcby Sirt1tm1.1Ygu Sirt1tm2Fwa Sirt1tm2.1Fwa 15/24 MGI mutant phenotypes (inferred from 12 alleles ) (MGI details for Sirt1) (see all 24):
SIRT1 for phenotypes About GeneDecksing
|
Pathways & Interactions for SIRT1 gene
(Pathways according to
EMD Millipore,
R&D Systems,
Cell Signaling Technology,
KEGG,
PharmGKB,
BioSystems,
Reactome,
Tocris Bioscience,
GeneGo (Thomson Reuters),
QIAGEN,
and/or UniProtKB,
Sets of similar genes according to GeneDecks,
Interaction Networks according to
SABiosciences,
and/or STRING,
Interactions according to 1UniProtKB,
2MINT,
3I2D, and/or
4STRING,
with links to IntAct and
Ensembl,
Ontologies according to Gene Ontology Consortium 01 Mar 2013 via
Entrez Gene).
About This Section
| Unified GeneCards pathways - 5/20 super-pathways (see all 20) About this table  See pathways by source
| Super-pathway | contained gene-specific pathways |
|---|
| 1 | NAD metabolism | | | 2 | Integrated Pancreatic Cancer Pathway | | | 3 | Non-homologous end-joining | | | 4 | Glucose / Energy Metabolism | | | 5 | Chromatin Regulation / Acetylation | |
Pathway sources See GeneCards unified pathways Show all pathways
3 EMD Millipore Pathways for SIRT1 2 Downloadable PowerPoint Slides of QIAGEN Pathway Central Maps for SIRT1 3
Cell Signaling Technology (CST) Pathways for SIRT1 2 GeneGo (Thomson Reuters) Pathways for SIRT1 5/12 BioSystems Pathways for SIRT1 (see all 12) 
1 PharmGKB Pathway for SIRT1
SIRT1 for pathways About GeneDecksing
Interactions:
SABiosciences Gene Network CentralTM Interacting Genes and Proteins Network for SIRT1
STRING Interaction
Network Preview (showing 5 interactants - click image to see 25)
 5/365 Interacting proteins for SIRT1 (Q96EB61, 2, 3 ENSP000002120154) via UniProtKB, MINT, STRING, and/or I2D (see all 365)About this table
Gene Ontology (GO): 5/89 biological process terms (GO ID links to tree view) (see all 89): About this table | GO ID | Qualified GO term | Evidence | PubMed IDs |
|---|
| GO:0000012 | single strand break repair |
IMP | -- | | GO:0000122 | negative regulation of transcription from RNA polymerase II promoter |
IMP | -- | | GO:0000183 | chromatin silencing at rDNA |
IDA | 18485871 | | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair |
IMP | -- | | GO:0000731 | DNA synthesis involved in DNA repair |
ISS | -- |
SIRT1 for ontologies About GeneDecksing
|
Drugs & Compounds for SIRT1 gene(Chemical Compounds according to UniProtKB, Enzo Life Sciences,
EMD Millipore, Tocris Bioscience
HMDB,
BitterDB, and/or
Novoseek, and Drugs according to
DrugBank,
Enzo Life Sciences, and/or
PharmGKB, with drugs/clinical trials/news
search links to CenterWatch)
About This Section
|
SIRT1 for compounds About GeneDecksing
 |
Enzo Life Sciences drugs & compounds for SIRT1 |
Compounds for SIRT1 available from Tocris Bioscience About this table
| Compound | Action |
CAS
# |
|---|
| Sirtinol | Selective sirtuin family deacetylase inhibitor | [410536-97-9] | | EX 527 | Selective SIRT1 inhibitor | [49843-98-3] | | Salermide | SIRT1 and SIRT2 inhibitor | [1105698-15-4] | | Splitomicin | Sir2p inhibitor | [5690-03-9] |
4 HMDB Compounds for SIRT1 About this table
| Compound | Synonyms |
CAS
# | PubMed Ids |
|---|
| NAD | 3-Carbamoyl-1-D-ribofuranosylpyridinium hydroxide 5'-ester with adenosine 5'-pyrophosphate (see all 28) | 53-84-9 | -- | | NADH | 1,4-Dihydronicotinamide adenine dinucleotide (see all 17) | 58-68-4 | -- | | Quercetin | 2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one (see all 13) | 117-39-5 | -- | | Resveratrol | 3,4',5-Trihydroxystilbene (see all 3) | 501-36-0 | -- | 10/12 Novoseek chemical compound relationships for SIRT1 gene (see all 12) About this table
| Compound |
-log (P-Val) |
Hits |
PubMed IDs for Articles with Shared Sentences (# sentences) |
| resveratrol |
88.7 |
111 |
15749705 (6), 20061378 (4), 19749157 (4), 18997065 (3) (see all 39) |
| nicotinamide |
80.5 |
26 |
17620057 (3), 12297502 (2), 18957417 (2), 19720090 (2) (see all 14) |
| nad+ |
77.8 |
47 |
19664641 (4), 17595514 (2), 19716821 (2), 20068143 (2) (see all 14) |
| lysine |
51.7 |
3 |
15744310 (1), 17098745 (1), 19578370 (1) |
| nadh |
41 |
8 |
19664641 (2), 20107110 (1), 19928762 (1), 19188449 (1) |
| fatty acid |
28.6 |
8 |
17646659 (2), 20160399 (1), 18709650 (1), 20033348 (1) |
| glucose |
23.7 |
25 |
18423418 (4), 19071085 (3), 20068143 (3), 15744310 (3) (see all 11) |
| lipid |
17.9 |
10 |
17936707 (2), 17646659 (2), 20033348 (1), 18239056 (1) (see all 6) |
| estrogen |
3.77 |
1 |
19690166 (1) |
| oxygen |
0 |
1 |
18922599 (1), 19303870 (1) |
Search CenterWatch for drugs/clinical trials and news about SIRT1 / SIR1 
|
Transcripts for SIRT1 gene(Secondary structures according to
fRNAdb,
GenBank/EMBL/DDBJ Accessions according to
Unigene
(Build 235 Homo sapiens; Mar 10 2013) or GenBank, RefSeq according to Entrez Gene,
DOTS (version 10), and/or
AceView,
transcript ids from Ensembl
with links to UCSC,
exon structure from GeneLoc,
alternative splicing isoforms according to ASD and/or
ECgene,
RNAi Products from
EMD Millipore,
siRNAs from
OriGene,
QIAGEN,
shRNA from
OriGene,
microRNA from QIAGEN,
Tagged/untagged cDNA clones from
OriGene,
SwitchGear Genomics,
GenScript,
DNA2.0,
Vector BioLabs,
Primers from
OriGene,
SABiosciences, and/or
QIAGEN
) About This Section
| REFSEQ mRNAs for SIRT1 gene (2 alternative transcripts): NM_001142498.1 NM_012238.4 Unigene Cluster for SIRT1: Sirtuin 1 Hs.369779 [show with all ESTs]Unigene Representative Sequence: NM_0122386 Ensembl transcripts including schematic representations, and UCSC links where relevant: ENST00000212015(uc001jnd.3 uc009xpp.3) ENST00000497639 ENST00000473922 ENST00000406900(uc001jne.3) ENST00000403579 ENST00000432464(uc010qis.2)
Clone Products: |  | OriGene Myc/DDK tagged cDNA clones in CMV expression vector in human, mouse, rat for SIRT1 (see all 5) OriGene untagged cDNA clones in CMV expression vector in human, mouse, rat for SIRT1 (see all 2) OriGene custom cloning services – gene synthesis, subcloning, mutagenesis,
variant library, vector shuttling 
| |  | GenScript: all cDNA clones in your preferred vector (see all 2): SIRT1 (NM_012238) | |  | DNA2.0 Custom Codon Optimized Gene
Synthesis Service for SIRT1 | |  | Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat SIRT1  |
Additional cDNA sequence: AF083106.2 AF235040.1 AK027686.1 AK074805.1 AK289743.1 AL136741.1 BC012499.1 BX648554.1 JQ768366.1 7 DOTS entries: DT.312320 DT.100749000 DT.97824709 DT.100748999 DT.91751505 DT.121247108 DT.100658352 24/87 AceView cDNA sequences (see all 87): AA608812 BF445130 AA452304 BM273130 CK820052 AW615289 BM354077 AI282390 NM_012238 BM980158 BQ219206 AI367389 AA461259 BU735905 BQ632248 AF235040 AA828109 AF083106 BU186744 BI258271 N68314 BF590111 AW967429 AI381553 GeneLoc Exon Structure
5/6 Alternative Splicing Database (ASD) splice patterns (SP) for SIRT1 (see all 6) About this scheme
| ExUns: | 1 | ^ | 2 | ^ | 3a | · | 3b | · | 3c | ^ | 4a | · | 4b | · | 4c | ^ | 5a | · | 5b | ^ | 6a | · | 6b | ^ | 7 | ^ | 8a | · | 8b | ^ | 9 | ^ | 10 | |
| SP1: | |   | |   | |   | |   | |   | |   | |   | |   | - |   | |   | |   | |   | |   | |   | |   | |   | |   | |
| SP2: | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |
| SP3: | |   | |   | |   | |   | |   | |   | |   | |   | - |   | - |   | |   | |   | |   | |   | |   | |   | |   | |
| SP4: | |   | |   | |   | |   | |   | |   | |   | |   | - |   | - |   | |   | |   | |   | |   | |   | |   | |   | |
| SP5: | |   | |   | - |   | - |   | - |   | |   | |   | |   | - |   | - |   | |   | |   | |   | |   | |   | |   | |   |
ECgene alternative splicing isoforms for SIRT1
|
Expression for SIRT1 gene
(RNA expression data according to
H-InvDB,
NONCODE,
miRBase, and
RNAdb,
Expression images according to data from
BioGPS,
Illumina Human BodyMap, and
CGAP
SAGE,
Sets of similar genes according to GeneDecks,
in vivo and in vitro expression data from LifeMap Discovery™,
plus additional links to
Genevestigator, and/or
SOURCE, and/or
BioGPS, and/or
UniProtKB,
PCR Arrays from
SABiosciences,
Primers from
OriGene,
SABiosciences, and/or
QIAGEN,
In Situ Hybridization Assays from Advanced Cell Diagnostics)
About This Section
| SIRT1 expression in normal human tissues (normalized intensities) See probesets specificity/sensitivity at GeneAnnot About this imageBioGPS CGAP TAG: --
About this image See SIRT1 Protein Expression from SPIRE MOPED and PaxDB Genevestigator expression for SIRT1
SOURCE GeneReport for Unigene cluster: Hs.369779 UniProtKB/Swiss-Prot: SIR1_HUMAN, Q96EB6Tissue specificity: Widely expressed SABiosciences Expression via Pathway-Focused PCR Arrays including SIRT1 (see all 9): | Epigenetic Chromatin Modification Enzymes in human mouse rat | | Polycomb & Trithorax Complexes in human mouse rat | | DNA Damage Signaling Pathway in human mouse rat | | Cancer PathwayFinder in human mouse rat | | Adipogenesis in human mouse rat |
Primer Products: |  | OriGene genome-wide validated SYBR primer pairs in human, mouse, rat for SIRT1 Browse OriGene validated miRNA SYBR primer pairs
| |  | SABiosciences RT2 qPCR Primer Assay in human, mouse, rat SIRT1 | |  | QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat SIRT1 | |  | QIAGEN QuantiFast Probe-based Assays in human, mouse, rat SIRT1 | In Situ Assay Products: |
| Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for SIRT1 |
Orthologs for SIRT1 gene
(Orthologs according to
1,2HomoloGene (2older version, for species not in 1newer version),
3euGenes,
4SGD
,
5MGI Mar 06 2013,
with possible further links to
Flybase
and/or
WormBase,
and/or
6Ensembl pan taxonomic compara ,
Gene Trees according to Ensembl and
TreeFam)
About This Section
|
This gene was present in the last universal common ancestor (LUCA).
Orthologs for SIRT1 gene from 7/28 species (see all 28) About this table
| Organism |
Taxonomic classification |
Gene |
Description |
Human Similarity |
Orthology Type |
Details |
chicken (Gallus gallus) |
Aves |
SIRT11 |
sirtuin 1 |
73.31(n) 72.63(a) |
  |
423646 NM_001004767.1 NP_001004767.1 |
lizard (Anolis carolinensis) |
Reptilia |
SIRT16SIRT56 |
-- |
70(a)19(a) |
1 ↔ 1possible ortholog |
GL343215.1(1274117-1291832) 4(57071927-57080042) |
tropical clawed frog (Xenopus tropicalis) |
Amphibia |
BX715176.12 |
-- |
74.64(n) |
  |
BX715176.1 |
zebrafish (Danio rerio) |
Actinopterygii |
BI476700.12 |
-- |
74.16(n) |
  |
BI476700.1 |
fruit fly (Drosophila melanogaster) |
Insecta |
Sir23 |
histone deacetylation NAD-dependent histone deacetylase |
57(a) |
  |
34A7 -- |
worm (Caenorhabditis elegans) |
Secernentea |
sir-2.11 , 3 |
Yeast regulatory protein SIR2 like3 Protein SIR-2.11 |
44(a)3 51.39(n)1 41.58(a)1 |
  |
IV(10363661-10366363)3 1779241 NM_069511.31 NP_501912.11 |
E. coli (Escherichia coli) |
Gamma proteobacteria |
cobB6 |
deacetylase of acs and cheY, regulates chemotaxis |
23(a) |
possible ortholog |
Chromosome(1178854-1179582) |
ENSEMBL Gene Tree for SIRT1 (if available) TreeFam Gene Tree for SIRT1 (if available)  |
Paralogs for SIRT1 gene(Paralogs according to
1HomoloGene, 2Ensembl, and 3SIMAP, Pseudogenes according to 4Pseudogene.org Build 68) About This Section
| -- |
Genomic Variants for SIRT1 gene(SNPs/Variants according to the
1NCBI SNP Database,
2Ensembl,
3PupaSUITE,
UniProtKB, and
DNA2.0,
Linkage Disequilibrium by HapMap,
Structural Variations(CNVs/InDels/Inversions) from the Database of Genomic Variants, Mutations from the Human Gene
Mutation Database (HGMD) and the Locus Specific Mutation
Databases (LSDB), Blood group antigen gene mutations by BGMUT,
Resequencing Primers from QIAGEN,
Cancer Mutation PCR Arrays and Assays and Copy Number PCR Arrays from SABiosciences)
About This Section
|
| Genomic Data | Transcription Related Data | Allele Frequencies | | SNP ID | Valid | Clinical significance | Chr 10 pos | Sequence | # | AA Chg | Type | More | # | Allele freq | Pop | Total sample | More |
|---|
HapMap Linkage Disequilibrium report for SIRT1 (69644427 - 69678147 bp)
Structural Variations (Copy Number Variations, Insertions/Deletions, Inversions) Database of Genomic Variants (DGV) variations for SIRT1: -- Human Gene Mutation Database (HGMD): SIRT1
 | SABiosciences Cancer Mutation PCR Assays |
|  | QIAGEN SeqTarget long-range PCR primers in human, mouse, rat for resequencing SIRT1 |
|
Disorders
/ Diseases for SIRT1 gene
(in which this Gene is Involved, According to MalaCards,
OMIM, UniProtKB,
the University of Copenhagen DISEASES
database, Novoseek,
Genatlas, GeneTests,
GAD,
HuGE Navigator,
and/or TGDB.)
About This Section
|
SIRT1 for disorders About GeneDecksing
OMIM gene information: 604479
OMIM disorders: --
20/58 diseases for SIRT1 (see all 58): About MalaCardsdiffuse large b-cell lymphoma nijmegen breakage syndrome b-cell lymphomas major depressive disorder xeroderma pigmentosum amyotrophic lateral sclerosis chronic obstructive pulmonary disease insulin resistance mental retardation syndrome metabolic disorders lateral sclerosis fatty liver disease differentiating neuroblastoma morbid obesity hyperphosphatemia mood disorder werner syndrome tauopathy liver disease pulmonary disease
4 diseases from the University of Copenhagen DISEASES database for SIRT1:Diabetes mellitus Fatty liver disease Vascular disease Cancer 8 Novoseek disease relationships for SIRT1 gene About this table
| Disease |
-log (P-Val) |
Hits |
PubMed IDs for Articles with Shared Sentences (# sentences) |
| cancer |
32.4 |
38 |
16596166 (3), 16288037 (3), 19149601 (2), 19060927 (2) (see all 16) |
| metabolic disorder |
31.7 |
4 |
19260974 (2), 17646659 (1), 19749157 (1) |
| neurodegeneration |
28.3 |
5 |
17581637 (2), 20061622 (2), 17936707 (1), 18838864 (1) (see all 7) |
| insulin sensitivity |
14.5 |
6 |
20107110 (4), 17646659 (1), 20439735 (1), 18928399 (1) |
| tumors |
6.42 |
20 |
19433578 (4), 19047049 (3), 12297502 (1), 19285066 (1) (see all 9) |
| cardiovascular diseases |
0.294 |
8 |
19260974 (2), 20061622 (1), 19815564 (1) |
| insulin resistance |
0 |
2 |
20107110 (1), 19260974 (1), 20068143 (1), 15850715 (1) |
| stroke |
0 |
2 |
20306310 (1), 18537630 (1) |
Genetic Association Database (GAD): SIRT1 Human Genome Epidemiology (HuGE) Navigator: SIRT1 (23 documents) Export disorders for SIRT1 gene to outside databases
|
Publications for SIRT1 gene (in
PubMed.
Associations of this gene to articles via
1Entrez Gene,
2UniProtKB/Swiss-Prot,
3HGNC,
4GAD,
5PharmGKB,
6HMDB,
7DrugBank,
8UniProtKB/TrEMBL,
9 Novoseek, and/or
10fRNAdb)
About This Section
|
PubMed articles for SIRT1 gene, integrated from 9 sources (see all 509): (articles sorted by number of sources associating them with SIRT1) | |  | Utopia: connect your pdf to the dynamic world of online information |
- Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. (PubMed id 10381378)1, 2, 3 Frye R.A. (1999)
- JNK2-dependent regulation of SIRT1 protein stability. (PubMed id 18838864)1, 2, 9 Ford J....Milner J. (2008)
- JNK1 phosphorylates SIRT1 and promotes its enzymatic activity. (PubMed id 20027304)1, 2, 9 Nasrin N....Bordone L. (2009)
- hSirT1-dependent regulation of the PCAF-E2F1-p73 apoptotic pathway in response to DNA damage. (PubMed id 19188449)1, 2, 9 Pediconi N....Levrero M. (2009)
- Transcriptional corepressor SMILE recruits SIRT1 to i nhibit nuclear receptor estrogen receptor-related receptor gamma transactivatio n. (PubMed id 19690166)1, 2, 9 Xie Y.B....Choi H.S. (2009)
- Sirtuin 1 (SIRT1) sequence variation is not associated with exceptional human longevity. (PubMed id 16257164)1, 4, 9 Flachsbart F....Nebel A. (2006)
- SIRT1 regulates HIV transcription via Tat deacetylation. (PubMed id 15719057)1, 2, 9 Pagans S.... Ott M. (2005)
- Carboxy-terminal phosphorylation of SIRT1 by protein kinase CK2. (PubMed id 19236849)1, 2, 9 Zschoernig B. and Mahlknecht U. (2009)
- SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation. (PubMed id 18004385)1, 2, 9 Vaquero A....Reinberg D. (2007)
- Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. (PubMed id 17964266)1, 2, 9 Kim E.J....Um S.J. (2007)
|
External Searches for SIRT1 gene
(in PubMed,
OMIM, and NCBI Bookshelf) About This Section
|
|
Genome Databases showing SIRT1 gene
(According to
Entrez Gene,
HGNC,
AceView,
euGenes,
Ensembl,
miRBase,
ECgene,
Kegg,
and/or
H-InvDB)
About This Section
|
|
Other Databases showing SIRT1 gene
(According to HUGE)
About This Section
| -- |
Specialized Databases showing SIRT1 gene(According to PharmGKB,
ATLAS, HORDE, IMGT, LEIDEN, UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL, Wikipedia and/or GeneReviews via UniProtKB/Swiss-Prot) About This Section
|
| Name | Description |
| PharmGKB entry for SIRT1 | Pharmacogenomics, SNPs, Pathways | | NIEHS-SNPs | http://egp.gs.washington.edu/data/sirt1/ |
|
| | |
About This Section
| Patent Information for SIRT1 gene: Search GeneIP for patents involving SIRT1
GeneCards and IP: Japan Patent Office Licenses GeneCards European Patent Office Licenses GeneCards Improving the IP Search
|
Products for SIRT1 gene(Antibodies, recombinant proteins, and assays from EMD Millipore, R&D Systems, OriGene, QIAGEN, GenScript, Cell Signaling Technology, SABiosciences, Novus Biologicals, Sino Biological, Enzo Life Sciences, Abcam, ProSpec, Uscn, Thermo Fisher Scientific, Gene Editing from DNA2.0, Clones from EMD Millipore, OriGene, GenScript, Sino Biological, DNA2.0, SwitchGear Genomics, Vector BioLabs, Cell lines from GenScript and LifeMap BioReagents, PCR Arrays from SABiosciences, Drugs and/or compounds from EMD Millipore, Tocris Bioscience, and/or
Enzo Life Sciences), In Situ Hybridization Assays from Advanced Cell Diagnostics About This Section
|
 | |
 | |
 |
| | | | OriGene Antibodies for SIRT1 | | OriGene shRNA RFP for SIRT1 | | OriGene 29mer shRNA kits in GFP-retroviral vector in human, mouse, rat for SIRT1 | | OriGene genome-wide validated SYBR primer pairs in human, mouse, rat for SIRT1 | | OriGene Protein Over-expression Lysate for SIRT1 | | Browse OriGene Fluorogenic Cell Assay Kits | | OriGene siRNA for SIRT1 | | OriGene 3'-UTR Clone for SIRT1 | | OriGene untagged cDNA clones in CMV expression vector in human, mouse, rat for SIRT1 | | OriGene Myc/DDK tagged cDNA clones in CMV expression vector in human, mouse, rat for SIRT1 | | Browse OriGene GFP tagged cDNA clones in CMV expression vector | | Browse OriGene MicroRNA Expression Plasmids | | Browse OriGene basic RS shRNAs | | Browse OriGene validated miRNA SYBR primer pairs | | OriGene Purified Protein for SIRT1 | | OriGene custom cloning services - gene synthesis, subcloning, mutagenesis,
variant library, vector shuttling | | OriGene Custom Antibody Services for SIRT1 | | OriGene Custom Protein Services for SIRT1 | | OriGene Custom Immunoassay Development | | |
| |  |
 |
| | QIAGEN Custom miScript Target Protector blocks miRNA-binding site of in human, mouse, rat SIRT1 | | QIAGEN SeqTarget long-range PCR primers in human, mouse, rat for resequencing SIRT1 | | QIAGEN PyroMark CpG Assay predesigned Pyrosequencing DNA Methylation assays in human, mouse, rat SIRT1 | | QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat SIRT1 | | QIAGEN QuantiFast Probe-based Assays in human, mouse, rat SIRT1 | | QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat SIRT1 |
| |
 |  |  |  | |
| | | Tocris compounds for SIRT1 |
| |  |  |  |  | | | | |
 |
 |
 |
 | | SIRT1 Proteins, Antibodies, CLIAs, and ELISAs |
| | | | Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for SIRT1 |
|  |  |  | | | ThermoFisher Antibody for SIRT1 |
| | Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat SIRT1 |
|
|
|
|